The patent cliff is taking its toll on big pharma, but that doesn't mean these companies are going to stand still and wither on the vine. In fact, three smart pharmaceuticals have snapped up hot biotechs with promising drug candidates to add to their portfolios. Watch and find out which companies bagged their prey and if the price they paid makes sense.
The beauty of big pharma is that they pay solid dividends while they develop new drugs. The Motley Fool has compiled a special free report outlining our nine top dependable dividend-paying stocks. It's called "Secure Your Future With 9 Rock-Solid Dividend Stocks." You can access your complimentary copy today at no cost! Just click here to discover the winners we've picked.